A global specialty contract research company.
Founded in 2000, Caprion Biosciences is a specialty CRO laboratory with world-renowned expertise in immune monitoring, proteomics and biomarker research. With an unwavering commitment to proactive scientific collaboration and service excellence, combined to the highest quality standards, we truly believe we can change the world of precision medicine.
Caprion recently united with HistoGeneX, a leading provider of immuno-oncology tissue pathology and genomics biomarker assessment services. The combined entities have nine laboratory facilities globally located in Canada, the United States, Belgium, UK, Australia, and China. Caprion and HistoGeneX are privately held and majority-owned by Arsenal Capital Partners.